{
    "name": "clomiphene",
    "comment": "Rx",
    "other_names": [
        "Clomid",
        "Serophene"
    ],
    "classes": [
        "Selective Estrogen Receptor Modulators"
    ],
    "source": "https://reference.medscape.com/drug/clomid-serophene-clomiphene-342752",
    "pregnancy": {
        "common": [
            "Use in pregnant women is contraindicated, as treatment does not offer benefit in this population; to avoid inadvertent administration during early pregnancy, appropriate tests should be utilized during each treatment cycle to determine whether ovulation and/or pregnancy occurs; patients should be evaluated carefully to exclude ovarian enlargement or ovarian cyst formation between each treatment cycle; the next course of therapy should be delayed until these conditions have been excluded",
            "Available human data from epidemiologic studies do not show apparent cause and effect relationship between clomiphene citrate periconceptual exposure and an increased risk of overall birth defects, or any specific anomaly"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "It is not known whether drug is excreted in human milk; because many drugs are excreted in human milk, caution should be exercised if drug is administered to a nursing woman; in some patients, therapy may reduce lactation"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Pregnancy",
                "Liver disease or history of liver disease",
                "Undiagnosed abnormal uterine bleeding",
                "Uncontrolled thyroid or adrenal dysfunction",
                "Endometrial cancer",
                "Ovarian cysts not due to PCOS"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Careful attention should be given to selection of candidates for therapy; pelvic examination is necessary prior to treatment and before each subsequent course",
                "Uterine fibroids, pituitary or ovarian failure may occur",
                "Potential for multiple births, especially at 100 mg dosage",
                "Use should be supervised by a practitioner with training and thoroughly familiar with infertility problems and their management",
                "Risk of visual disturbance (like scotoma & photopsia); patients should be warned that visual symptoms may render activities such as driving a car or operating machinery more hazardous than usual, particularly under conditions of variable lighting; while etiology of visual symptoms is not yet understood, patients with any visual symptoms should discontinue treatment and have complete ophthalmological evaluation carried out promptly",
                "Cases of hypertriglyceridemia reported; preexisting or family history of hyperlipidemia and use of higher than recommended dose and/or longer duration of treatment are associated with risk of hypertriglyceridemia; periodic monitoring of plasma triglycerides is recommended in patients with preexisting or family history of hyperlipidemia; pretreatment screening of triglyceride levels is recommended in patients initiating therapy",
                "Cases of pancreatitis reported",
                "Prolonged use of clomiphene citrate tablets USP may increase risk of a borderline or invasive ovarian tumor",
                "Presence of organic intracranial lesion, including pituitary tumor",
                "Ovarian enlargement may be accompanied by abdominal distention or abdominal pain and generally regresses without treatment within days or weeks of discontinuing therapy; withhold therapy if ovaries are abnormally enlarged until size returns to pretreatment size; reduce dose and duration of future cycles"
            ],
            "specific": [
                {
                    "type": "Ovarian hyperstimulation syndrome",
                    "description": [
                        "Ovarian hyperstimulation syndrome is a rare exaggerated response to ovulation induction therapy",
                        "May begin within 24 hours of treatment but may become severe 7 to 10 days after therapy",
                        "Symptoms may include abdominal distention discomfort, nausea, diarrhea, vomiting",
                        "Severe symptoms may include severe abdominal pain ascites, hypotension, anuria/oliguria",
                        "Treatment is primarily symptomatic, including analgesics, fluid and electrolyte management, and prevention of thromboembolic complications"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Contraindicated",
            "interaction_with": "ospemifene",
            "description": {
                "common": "ospemifene, clomiphene.\nEither increases effects of the other by pharmacodynamic synergism. Contraindicated."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "benazepril",
            "description": {
                "common": "clomiphene, benazepril.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Increases risk of hypotension."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Abnormal bone development",
            "percent": null
        },
        {
            "name": "skeletal malformations of the skull",
            "percent": null
        },
        {
            "name": "face",
            "percent": null
        },
        {
            "name": "nasal passages",
            "percent": null
        },
        {
            "name": "jaw",
            "percent": null
        },
        {
            "name": "hand",
            "percent": null
        },
        {
            "name": "limb",
            "percent": null
        },
        {
            "name": "ectromelia including amelia",
            "percent": null
        },
        {
            "name": "hemimelia",
            "percent": null
        },
        {
            "name": "and phocomelia",
            "percent": null
        },
        {
            "name": "foot",
            "percent": null
        },
        {
            "name": "clubfoot",
            "percent": null
        },
        {
            "name": "spine",
            "percent": null
        },
        {
            "name": "and joints",
            "percent": null
        },
        {
            "name": "Cardiac abnormalities",
            "percent": null
        },
        {
            "name": "septal heart defects",
            "percent": null
        },
        {
            "name": "muscular ventricular septal defect",
            "percent": null
        },
        {
            "name": "patent  ductus arteriosus",
            "percent": null
        },
        {
            "name": "tetralogy of Fallot",
            "percent": null
        },
        {
            "name": "and coarctation of the aorta",
            "percent": null
        },
        {
            "name": "Chromosomal disorders",
            "percent": null
        },
        {
            "name": "Downs syndrome",
            "percent": null
        },
        {
            "name": "Ear abnormalities and deafness",
            "percent": null
        },
        {
            "name": "Gastrointestinal tract abnormalities",
            "percent": null
        },
        {
            "name": "cleft lip and palate",
            "percent": null
        },
        {
            "name": "imperforate anus",
            "percent": null
        },
        {
            "name": "tracheoesophageal fistula",
            "percent": null
        },
        {
            "name": "diaphragmatic hernia",
            "percent": null
        },
        {
            "name": "omphalocele",
            "percent": null
        },
        {
            "name": "Genitalia abnormalities",
            "percent": null
        },
        {
            "name": "hypospadias",
            "percent": null
        },
        {
            "name": "cloacal exstrophy",
            "percent": null
        },
        {
            "name": "Lung tissue malformations",
            "percent": null
        },
        {
            "name": "Malformations of the eye and lens",
            "percent": null
        },
        {
            "name": "cataract",
            "percent": null
        },
        {
            "name": "Neoplasms",
            "percent": null
        },
        {
            "name": "neuroectodermal tumor",
            "percent": null
        },
        {
            "name": "thyroid tumor",
            "percent": null
        },
        {
            "name": "hepatoblastoma",
            "percent": null
        },
        {
            "name": "lymphocytic  leukemia",
            "percent": null
        },
        {
            "name": "Nervous system abnormalities",
            "percent": null
        },
        {
            "name": "neural tube defects",
            "percent": null
        },
        {
            "name": "anencephaly",
            "percent": null
        },
        {
            "name": "meningomyelocele",
            "percent": null
        },
        {
            "name": "microcephaly",
            "percent": null
        },
        {
            "name": "and hydrocephalus",
            "percent": null
        },
        {
            "name": "Renal abnormalities",
            "percent": null
        },
        {
            "name": "renal agenesis and renal dysgenesis",
            "percent": null
        },
        {
            "name": "Others",
            "percent": null
        },
        {
            "name": "dwarfism",
            "percent": null
        },
        {
            "name": "mental retardation",
            "percent": null
        }
    ]
}